![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Groupe Crit | EU:CEN | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 57.00 | 56.80 | 57.00 | 57.00 | 57.00 | 57.00 | 84 | 08:00:00 |
RNS Number:2346U CeNeS Pharmaceuticals PLC 14 January 2004 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The Company received notification today that a client of ISIS Asset Management plc, Active Capital Trust, following the disposal of 2,500,000 ordinary shares of 1p each between 12th and 13th January 2004, has an interest in 13,700,000 ordinary shares of 1p each in the capital of the Company representing 5.47 per cent. of the issued share capital of the Company. Further information Neil Clark, CeNeS Pharmaceuticals plc 01223 266 466 14 January 2004 This information is provided by RNS The company news service from the London Stock Exchange END HOLUSSSRSSRAAAR
1 Year Groupe Crit Chart |
1 Month Groupe Crit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions